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Abstract
Background: Epidemiological studies on health effects of air pollution have consistently shown adverse cardiovascular
effects. Toxicological studies have provided evidence for thrombogenic effects of particles.
A prospective panel study in a susceptible population was conducted in Erfurt, Germany, to study the effects of daily
changes in ambient particles on various blood cells and soluble CD40ligand (sCD40L, also known as CD154), a marker
for platelet activation that can cause increased coagulation and inflammation.
Blood cells and plasma sCD40L levels were repeatedly measured in 57 male patients with coronary heart disease (CHD)
during winter 2000/2001. Fixed effects linear regression models were applied, adjusting for trend, weekday and
meteorological parameters.
Hourly data on ultrafine particles (UFP, number concentration of particles from 0.01 to 0.1 μm), mass concentration of
particles less than 10 and 2.5 μm in diameter (PM10, PM2.5), accumulation mode particle counts (AP, 0.1–1.0 μm),
elemental and organic carbon, gaseous pollutants and meteorological data were collected at central monitoring sites.
Results: An immediate increase in plasma sCD40L was found in association with UFP and AP (% change from geometric
mean: 7.1; CI: [0.1, 14.5] and 6.9; CI: [0.5, 13.8], respectively). Platelet counts decreased in association with UFP showing
an immediate, a three days delayed (lag 3) and a 5-day average response (% change from the mean: -1.8; CI: [-3.4,-0.2]; -
2.4; CI: [-4.5,-0.3] and -2.2; CI: [-4.0,-0.3] respectively).
Conclusion: The increased plasma sCD40L levels support the hypothesis that higher levels of ambient air pollution lead
to an inflammatory response in patients with CHD thus providing a possible explanation for the observed association
between air pollution and cardiovascular morbidity and mortality in susceptible parts of the population.
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Particulate air pollution has consistently been associated
with adverse cardiovascular events [1-5], however the
underlying pathophysiological mechanisms remain
unclear.
Different pathways, including systemic inflammation, an
imbalance in coagulation factors and effects on the auto-
nomic nervous system have been postulated [6].
Recent toxicological studies have demonstrated a pro-
thrombogenic effect of diesel exhaust particles in ham-
sters, as well as an activation of platelets [7], thus provid-
ing one possible explanation for the observed effects.
Studies on rats additionally showed evidence for throm-
bus formation after the deposition of ultrafine particles
(UFP, number concentration of particles from 0.01 to 0.1
μm in diameter,) in the respiratory tract [8] while a study
in mice indicated a procoagulant effect, but no inflamma-
tion after intra-arterial infusion of UFP [9]. Nemmar et al.
[10] demonstrated in hamster models that ultrafine poly-
styrene particles can modulate thrombus formation and
Suwa et al. [11] observed a systemic inflammatory
response and a progression of the atherosclerotic process
in hyperlipidemic rabbits in association with PM10 (mass
concentration of particles < 10 μm in diameter).
We previously observed a delayed increase in levels of C-
reactive protein (CRP) and intercellular adhesion mole-
cule 1 (ICAM-1) above the 90th percentile for an increase
in accumulation mode particles (AP, 0.1–1.0  μm), UFP
and PM10 in the same patients with coronary heart disease
(CHD) we report about here [12]. Clotting factors, how-
ever, did not reveal a clear picture. While prothrombin
fragment 1+2 increased with a delay of four days in asso-
ciation with ambient particles, no consistent results were
found for fibrinogen. For FVII clear and consistent nega-
tive associations were observed [12].
In addition to the above mentioned markers, we analysed
now the effect of particulate air pollution on blood cells
(platelets, leukocytes, erythrocytes, haemoglobin) and
soluble CD40L (sCD40L). CD40L, a glycoprotein released
from activated platelets [13], promotes the process of
thrombus formation in vivo [14]. Moreover, both surface
bound and released CD40L is proinflammatory, pro-
thrombotic and proatherogenic [15]. CD40L can strongly
activate CD40 bearing cells such as white blood cells,
endothelial cells and platelets themselves [16,13].
The aim of this analysis was to study the effects of ambient
air pollution on blood cells and sCD40L in a susceptible
population in view of previous results. We hypothesised
that sCD40L, as well as blood cell counts, would increase
in tandem with increased ambient particles. For the anal-
ysis, repeated measurements of sCD40L, platelets, leuko-
cytes, erythrocytes and haemoglobin were related to




In a prospective panel study conducted between October
15th 2000 and April 27th 2001 in Erfurt, Germany as part
of the University of Rochester (Rochester, NY, USA) Parti-
cle Center Study current non-smokers, aged 50 years or
older, with physician-diagnosed CHD were recruited
through a local cardiologist. Patients who had pacemak-
ers, recent (less than three months ago) myocardial infarc-
tion, bypass-surgery or balloon dilatation, type 1 diabetes
or were on anti-coagulation therapy (except for anti-plate-
let agents) were not included. From each subject a signed
informed consent was obtained.
Sixty-one male patients with CHD were scheduled for 12
subsequent clinical examinations over a period of six
months. Each clinical visit included a short interview and
the withdrawal of a blood sample under non-coagulating
conditions using citrate tubes. Blood cells from whole
blood were counted immediately following each visit. For
the baseline characterisation a detailed questionnaire was
administered at the first visit, regarding health status, pul-
monary and cardiac symptoms, medication intake and
smoking history.
All methods used in the study were conducted according
to Standard Operating Procedures (SOP) and were tested
beforehand in a two-week pilot study. The study protocol
was approved by the German Ethics Commission "Bayer-
ische Landesaerztekammer".
Study subjects
Out of the initial 61 patients 57 remained for the analyses.
One patient refused to participate; two were excluded due
to diseases that led to a change in blood markers (leukae-
mia, lymphoma) and the fourth patient because of con-
stantly elevated levels of leukocytes and erythrocytes,
indicating an unknown underlying disease. Most patients
(n = 55) participated in all of the 12 scheduled visits,
while two took part in only nine and eight examinations
respectively. For comparability reasons we included the
same blood samples that were included in the previous
analyses [12]. If patients reported an acute infection and/
or surgery during the two weeks prior to the examination
or if the nurses saw signs of an acute infection the blood
samples were excluded from the analysis (46 blood sam-
ples of 19 different patients). Finally, not all patients were
able to give the scheduled amount of blood at each visit.
Therefore, between 539 and 579 blood samples remained
for analysis depending on the marker/blood cell.Page 2 of 14
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For each patient the clinical visits were scheduled on the
same weekday (Monday to Friday) and time (8:00 am to
5:00 pm) once every two weeks.
At each visit a sample of 4 × 1.0 ml citrate plasma was
drawn (Becton Dickinson, NJ, USA) using 20 or 21-gauge
needles. Samples were cooled down and centrifuged at
2500 g for 20 minutes at a temperature of 4°C and the cell
free aliquots stored at -20°C, immediately.
After the collection was completed the blood samples
were shipped to the USA on dry ice for sCD40L determi-
nation. sCD40L levels in blood plasma were determined
with an ELISA for sCD40L. For the analyses of sCD40L all
samples were processed the same and appropriately
diluted so that at least one value fell on the standard
curve. A 96-well microtiter plate was coated with 3 μg per
ml of mouse anti-human sCD40L antibody (gift of Dr.
Marilyn Kerry, Boeringer-Ingelheim, CT, USA) and
allowed to incubate overnight at room temperature. A
blocking buffer consisting of PBS (phosphate buffered
normal saline) -1% BSA (bovine serum albumin) and
0.1% NaN3 was added to the plate and incubated for one
hour. The plate was then washed three times using a wash-
ing buffer consisting of PBS containing 0.05% Tween 20
and 0.1% NaN3. Recombinant human sCD40L standards
(Bender Medsystems, Vienna, Austria) were added to each
plate using serial dilutions in blocking buffer to create a
standard curve of 6.25 to 400 pg/ml. Samples were diluted
as needed with blocking buffer and added to the plate.
The plates were incubated for two hours and then washed
three times with washing buffer. Biotinylated mouse
monoclonal anti-human CD40L antibody (Ancell, Bay-
port, MN, USA) was added to each well (2 μg per ml in
blocking buffer) and incubated for two hours. The plates
were washed three times with washing buffer. A 1 to 1000
dilution of streptavidin-alkaline phosphatase (Bio-Rad
Laboratories, Hercules, CA, USA) was added to each well
and allowed to incubate 30 minutes before washing three
times with washing buffer. The ELISA plates were then
developed using an alkaline phosphatase substrate kit
(Bio-Rad Laboratories, Hercules, CA, USA) as per manu-
facturer's directions for use. After incubating 20–30 min-
utes in the dark, the ELISA plates were promptly read
using a microplate reader (Bio-Rad, Hercules, CA, USA) at
wavelength of A405 with a reference of A610 [17].
The haemograms of the specimens including platelets,
leucocytes, erythrocytes and haemoglobin were obtained
by an Abbott Cell-Dyn 1300 cell counter (Abbott, Ill,
USA) from whole blood immediately following each visit.
Air pollution monitoring
The concentrations of different ambient air pollutants
were measured at a fixed monitoring site representing
urban background levels. The measurement site was
located approximately one kilometre south of the Erfurt
city centre and 30 m from the nearest major road. The
measurement site was established especially for carrying
out epidemiological studies, [18] and all measurements
were conducted according to the SOP developed within
the framework of previous studies [19].
Continuous UFP counts, accumulation mode particle
counts and fine particle mass (PM2.5, particles < 2.5 μm
diameter) were measured with a Mobile Aerosol Spec-
trometer (MAS). The MAS, described previously [20] con-
sisted of two different commercially available instruments
covering different size ranges. Particles in the size range
from 0.01 μm to 0.5 μm were measured using a differen-
tial mobility particle sizer (DMPS). Particles in the size
range from 0.1 μm up to 2.5 μm were classified by an opti-
cal laser aerosol spectrometer (LAS).
Mass concentration of PM10 data was collected by the
tapered element oscillating microbalance method (TEOM
1400a) and continuous data on elemental and organic
carbon (EC, OC) were measured with an ambient carbon
monitor (ACM 5400) (Rupprecht & Patashnick, Co., Inc.,
Albany, NY, USA). Data on meteorological variables for
this period as well as concentrations of gaseous air pollut-
ants were collected from existing networks.
Missing values in the ambient particle pollutants UFP and
PM2.5 between 20th of January and 13th of February 2001
and one missing day (31st of March 2001) in the meteor-
ological variables of temperature and relative humidity
were either imputed by a linear regression model (UFP) or
replaced based on corrected concurrent measurements
with other devices (PM2.5, temperature, relative humid-
ity). The squared multiple correlation for the UFP regres-
sion models was 0.96.
Statistical analyses
For each person five individual periods covering 24-hour
averages of pollutants were calculated if more than 2/3 of
the hourly measurements were available for this period.
We used the 24 hours immediately preceding each clinical
visit (lag 0), the period 24 to 47 hours (lag1) up to day 5
prior to the visit (lags 2 to 4) and 5-day running means to
measure cumulative effects.
Generalized additive models including pollutant and con-
founder variables were used for fixed effects regression
with individual intercepts for each patient. Long-term
time trend, weekday of the visit and the meteorological
parameters air temperature, relative humidity and baro-Page 3 of 14
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as potential confounders. As the visits took place in two
week intervals, we assumed that no adjustment was neces-
sary for autocorrelation in the pollution data and most of
the blood markers. For the erythrocytes, which have a
longer half life, sensitivity analyses were conducted to
check for autocorrelation. Eight patients who showed an
indication for autocorrelation for erythrocytes were
excluded and the reduced dataset was re-analysed.
sCD40L needed to be log-transformed to fulfil the model
assumption of residual normality. To explore the shape of
the association between confounders and blood markers,
non-parametric smooth functions based on locally
weighted least squares were applied. Model fit was rated
based on the Akaike Information Criterion (AIC). In the
final model, non-parametric smooth functions were
replaced by appropriate polynomials (degree 2 or 3) or
natural splines with similar number of degrees of free-
dom. Parametric functions were used to avoid an under-
estimation of the standard errors which can occur if
concurvity is present in the data, as is often the case in air
pollution studies [21].
Effect estimates are presented as percent change of the
mean or geometric mean together with 95 percent confi-
dence intervals (95%CI) based on an increase in air pollu-
tion concentrations from the 1st to the 3rd quartile
(interquartile range, IQR). Data were analyzed using the
statistical package SAS Version 8.2 (SAS Institute Inc.) and
S-Plus Version 6.0 (Math Soft Inc.). A subgroup analysis
was conducted comparing patients who were on lipid-
lowering drugs to those who were not.
Results
Patient characteristics
The patient characteristics are summarized in Table 1. The
study population comprised 57 non-smoking men with
CHD, between 51 and 76 years. Although all patients were
current non-smokers, three quarters of the patients were
former smokers. The majority took acetylsalicylic acid,
half of them were on lipid-lowering medication like stat-
ins and three of the patients used platelet aggregation
inhibitors.
Air pollutants
The distributions of the 24-hour average concentrations
of the particulate and gaseous pollutants, as well as of the
meteorological data are shown in Table 2.
Due to the different measurement methods mean values
for PM10 and PM2.5 are almost the same. The TEOM
Table 1: Characteristics of the study population in Erfurt, Germany, winter 2000/2001
Mean (SD‡)
Age [years] 66 (6.0)
BMI* [kg/m2] 28 (3.4)
No. (%)
History of
Coronary heart disease 57 (100)
Angina pectoris 40 (68)
Myocardial infarction 43 (75)
Bypass surgery/balloon dilatation 49 (86)
Stroke 3 (5)
Diabetes mellitus 13 (23)
Hypertension 40 (70)
Chronic bronchitis 2 (4)
COPD† 5 (9)
Hay fever 2 (4)
Chronic kidney disease 6 (11)
Smoking
Never smoker 15 (26)
Ex-smoker 42 (74)
Medication use Anti-hyperlipidemic medication 29 (51)
Platelet aggregation inhibitors
Acetylsalicylic acid 52 (91)
Thienopyridines 3 (5)
* BMI, Body mass index
† COPD, Chronic obstructive pulmonary disease
‡ SD, standard deviationPage 4 of 14
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ature of 50°C, which can lead to partial or total volatiliza-
tion of light volatile compounds, producing a recorded
mass below that of the true aerosol mass in ambient air
[22,23]. The MAS, on the other hand, provides online
measurements, so no volatilization is to be expected.
PM10, PM2.5 and AP were highly correlated (r = 0.86 to
0.91), whereas UFP were only moderately correlated with
PM10 and PM2.5 (r = 0.57 and 0.41 respectively) (Figure 1).
NO and UFP also showed a high correlation (r = 0.83).
Blood parameters
Table 3 shows the values of sCD40L, platelets, leukocytes,
erythrocytes and haemoglobin in the analysed blood sam-
ples. Erythrocytes and haemoglobin were highly corre-
lated (r = 0.74) and leukocytes and platelets showed a
moderate correlation (r = 0.52). No correlation was seen
between sCD40L and all of the analysed blood cells (r = -
0.02 to -0.32).
Regression results
sCD40L, platelets and leukocytes
The results of the regression for sCD40L, platelets and leu-
kocytes are given in Table 4. Linear regression suggested
an increase in sCD40L in association with 24-h average
ambient particles before the examination. The effects were
significant for UFP and AP. The effect of the concentra-
tions of UFP was supported by the result for NO, a gase-
ous marker for UFP, which also showed an increase with
lag 0 that was borderline significant (%change from geo-
metric mean: 3.2; CI: [-0.2; 6.8], p < 0.07) (data not
shown). Additionally, a decrease with lag 3 was found
that was limited to UFP.
For platelets, significant results were limited to UFP show-
ing an immediate and a three day delayed decrease as well
as a negative association with the 5-day average concen-
tration. The linear regression of leukocytes showed con-
sistently negative associations for UFP, AP and PM2.5, with
lag 0 and in addition borderline significant effects for AP
with lag 3 and the 5-day average.
To further investigate the immediate effects, we split the
24 hours into four six hour periods (0–5 h, 6–11 h, 12–17
h and 18–23 h) and analysed the results for UFP. While
the effect for sCD40L was most prominent for the expo-
sure time period 12 to 17 hours prior to the blood with-
drawal, platelets and leukocytes showed an immediate
decrease in the first six hours and a delayed one between
18 to 23 hours (Figure 2).
Erythrocytes and haemoglobin
Erythrocytes and haemoglobin, in contrast, were mainly
associated with PM2.5 and PM10 showing negative associa-
tions for the 2 day-lagged concentrations and 5-day aver-
ages. Erythrocytes showed additional associations with
PM10 at lags 1 and 3 and with UFP for lag 3 and the 5-day
average exposure (Table 5).
Sensitivity analyses
Excluding eight patients whose data indicated possible
autocorrelation did not change the results for erythrocytes
significantly. Except for slightly larger confidence inter-
vals, most probably due to the reduced number of data
points, no major changes were found when comparing
the whole dataset to the reduced one. The estimate for
PM10 with lag2, for example showed a % change from the
mean of -0.8, 95% CI: [-1.3; -0.2].
Table 2: 24-h-averages of air pollutants and meteorological variables between October 2000 and April 2001
Variable N Mean (± SD#) Min. 25% Median 75% Max. IQR†† IQR†† 5-day average
UFP* [n/cm3] 196 12602 (± 6455) 2542 7326 11444 17332 34294 10005 6821
AP* [n/cm3] 167 1593 (± 1034) 328 821 1238 2120 4908 1299 1127
PM2.5*[μg/m3] 197 20.0 (± 15.0) 2.6 9.7 14.9 26.1 83.7 16.4 12.2
PM10*[μg/m3] 154 20.0 (± 13.0) 5.4 10.8 15.6 26.0 74.5 15.2 12.8
NO†[μg/m3] 196 24.4 (± 27.7) 4.0 6.8 12.3 30.3 137.6 23.5 21.0
Air temperature‡[°C] 198 4.1 (± 4.8) -10.4 0.5 4.4 7.9 13.2 7.4 5.9
Barometric pressure [hPa] 198 973.4 (± 9.7) 949.5 966.3 972.9 980.0 995.7 13.6 10.8
Relative humidity§ [%] 198 83.5 (± 8.8) 55.8 78.9 84.3 88.8 100.0 10.0 9.1
* UFP, ultrafine particles, number concentration of particles with a size range of 0.01 to 0.1 μm in diameter
13% of the hourly measurements were imputed,
AP, Accumulation mode particles, particles with a size range of 0.1 to 1.0 μm,
PM2.5, mass concentration of particles less than 2.5 μm in diameter
15% of the hourly measurements were imputed
PM10, mass concentration of particles less than 10 μm in diameter
† NO, Nitrogen monoxide;
‡ Temperature: 0.5% of the hourly measurements were imputed
§Relative humidity: 0.5% of the hourly measurements were imputed
# SD, standard deviation
†† IQR, inter quartile rangePage 5 of 14
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We found no difference in the results for patients who
were on lipid-lowering drugs (mainly statins) compared
to those who were not (data not shown). As more than
90% of our patients used platelet aggregation inhibitors
(Table 1) a subgroup analysis for those with and without
intake could not be conducted.
Discussion
Summary
Our findings support the concept that sCD40L levels in
plasma increase in association with elevated ambient air
particle concentrations 24 hours before the examination.
The effects were limited to number concentrations of UFP
and AP, dominated by particles below 500 nm. Platelets
and leukocyte counts decreased in association with an
increase in UFP and AP shortly before the examination.
For erythrocytes and haemoglobin the main findings were
delayed decreases in association with PM2.5 and PM10.
Table 3: Levels of sCD40L, platelets, leukocytes, erythrocytes and haemoglobin for 57 patients with coronary heart disease
N Mean SD* Min Median Max
sCD40L† [pg/ml] 539 5246 4481 115 4129 44260
Platelets [103/μl] 578 185 65 41 175 603
Leukocytes [103/μl] 579 6.8 1.7 2.8 6.7 14.5
Erythrocytes [106/μl] 578 4.6 0.4 3.4 4.6 6.0
Haemoglobin [g/dl] 579 14.1 1.0 8.7 14.2 17
*SD: Standard deviation of all values
†sCD40L, soluble CD40 Ligand
Time series of number concentrations of particles sized 0.01 to 0.1 μm (ultra fine particles, UFP) and mass concentrations of particles l s than 2.5 μm in diameter (PM2.5) together with air temperat re in Erfurt, Germany between O tob r 2000 and April 2001F gur  1
Time series of number concentrations of particles sized 0.01 to 0.1 μm (ultra fine particles, UFP) and mass 
concentrations of particles less than 2.5 μm in diameter (PM2.5) together with air temperature in Erfurt, Ger-
many between October 2000 and April 2001. UFP: ultrafine particles (number concentration of particles with a size 
range of 0.01 to 0.1 μm); PM2.5: mass concentration of particles less than 2.5 μm in diameter.Page 6 of 14
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CD40L, a trimeric transmembrane protein of the tumor
necrosis family, was originally identified on cells of the
immune system [24]. It binds to CD40 on cells such as
endothelial cells, monocytes and dendritic cells [25].
CD40L is also stored in platelets and translocated to the
platelet surface upon stimulation within seconds after
activation in vitro and in vivo [14,13]. Surface expressed
CD40L is then cleaved and/or released from the platelet
over a period of minutes to hours, subsequently generat-
ing a soluble fragment, soluble CD40L (sCD40L) [13].
sCD40L can promote inflammatory or thrombotic
response by causing further platelet activation [13,26].
This can occur through binding to platelet CD40 [14] or
to the integrin [15]. More than 95% of the circulating
CD40L exists in platelets [27,13]. André et al. [28] there-
fore deduced that platelet stimulatory events must be con-
sidered in the biological and pathological context of
CD40L function. Henn et al. [14] concluded from their
study that the generation of inflammatory signals by
platelets may occur following acute mechanical damage
of the endothelium, an infection of the vascular system,
and also in the pathogenesis of atherosclerosis and vascu-
lar infarction. Our results indicate an immediate increase
in sCD40L in association with increased levels of UFP. A
possible explanation is that UFP act as a stimulant for
platelets, leading to their release of CD40L into the circu-
lation. According to Geiser et al. [29] particles rapidly
Table 4: Association between air pollution and blood parameters; 57 male patients with coronary heart disease
sCD40L [pg/ml] Platelets [103/μl] Leucocytes [103/μl]
%change GM$ 95% CI$ %change mean 95% CI %change mean 95% CI
UFP§
lag0 7.1* 0.1; 14.5 -1.8* -3.4; -0.2 -2.4* -4.5; -0.2
lag1 0.3 -6.6; 8.6 -1.1 -2.9; 0.6 -2.1† -4.4; 0.2
lag2 0.6 -5.9; 8.6 -1.0 -2.9; 0.8 0.2 -2.4; 2.8
lag3 -8.5* -15.8; -0.5 -2.4* -4.5; -0.3 -1.5 -4.4; 1.4
5-day-
average
-0.7 -7.6; 6.8 -2.2* -4.0; -0.3 -1.6 -4.1; 0.8
AP§
lag0 6.9* 0.5; 13.8 -1.0 -2.5; 0.5 -1.9* -3.8; -0.1
lag1 -1.1 -8.0; 6.4 -0.4 -2.1; 1.6 -0.6 -2.9; 1.6
lag2 -4.9 -11.9; 2.7 0.8 -1.0; 2.4 -0.6 -3.2; 2.0
lag3 -3.8 -10.3; 3.2 0.0 -1.8; 1.7 -2.3† -4.6; 0.1
5-day-
average
-1.3 -9.9; 8.1 -0.9 -3.0; 1.3 -2.7† -5.5; 0.1
PM2.5§
lag0 1.5 -4.0; 7.3 -0.6 -1.9; 0.7 -1.6* -3.2; 0.0
lag1 0.2 -5.4; 6.2 0.1 -1.3; 1.5 -0.4 -2.2; 1.4
lag2 -2.6 -8.0; 3.1 0.5 -0.9; 1.9 -0.2 -2.1; 1.7
lag3 0.5 -3.9; 5.0 0.2 -1.1; 1.5 -0.8 -2.4; 0.7
5-day-
average
0.2 -5.4; 6.2 -0.4 -1.9; 1.2 -1.6 -3.5; 0.3
PM10§
lag0 1.6 -3.5; 7.0 -0.4 -1.9; 1.0 -1.1 -2.8; 0.7
lag1 1.1 -5.4; 7.9 0.4 -1.4; 2.3 -0.5 -2.6; 1.5
lag2 -3.5 -8.9; 2.2 0.5 -1.4; 2.3 0.1 -2.1; 2.4
lag3 -1.4 -6.0; 3.4 -0.1 -1.6; 1.4 -0.7 -2.6; 1.2
5-day-
average
-1.2 -7.8; 5.8 0.0 2.1; 0.0 -1.1 -3.6; 1.4
*p < 0.05; †p < 0.10
§ UFP: ultrafine particles (number concentration of particles with a size range of 0.01 to 0.1 μm);
AP: accumulation mode particles (particles with a size range of 0.1 to 1.0 μm); PM2.5: mass concentration of particles less than 2.5 μm in diameter; 
PM10: mass concentration of particles less than 10 μm in diameter;
$CI: confidence interval, GM: geometric meanPage 7 of 14
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Association between UFP and sCD40L, platelets and leukocytes, 6-hour periods and lag 0 (0–23 hours)Figure 2
Association between UFP and sCD40L, platelets and leukocytes, 6-hour periods and lag 0 (0–23 hours). 
sCD40L: soluble CD40Ligand. UFP: ultrafine particles (number concentration of particles with a size range of 0.01 to 0.1 μm).
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were able to demonstrate that inhaled particles can leave
the lungs and enter circulation. However, the circum-
stances under which particles translocate have to be eluci-
dated and there are other studies that report no
translocation [31] or that translocation might depend on
lung permeability [32]. Moreover, studies showed
increased thrombus formation, an early response presum-
ably due to direct translocation of particles and a 24-hours
delayed response due to inflammation in the alveolar
region [7,10]. Berry et al. [33] found nanoparticles in
blood platelets that had been instilled into rat lungs
beforehand. We hypothesise that translocated particles
might be responsible for the observed positive association
between UFP and the levels of sCD40L.
So far, only a few studies regarding the effect of air pollu-
tion particles on the CD40/CD40L pathway have been
published [34,35]. In accordance with our results these
studies indicate a positive association between ambient
particles and sCD40L/CD40 despite the different study
design.
Platelets
Many studies have been published on the association of
platelets and ambient air pollution, but the results are not
consistent [36-41]. Considering our results of increased
plasma levels of sCD40L, the decrease in platelets could
be the result of platelet aggregation, either due to a direct
activation of the platelets or via an increase in adhesion
molecules (Figure 3). Inwald et al. [42] showed that plate-
lets can be activated through ligation of constitutively
expressed CD40L. They hypothesised that platelet-derived
CD40L may have the capacity to stimulate resting plate-
lets by binding to CD40 during direct cell-cell contact or
via release of sCD40L. sCD40L has been shown to initiate
inflammatory and thrombotic response by causing further
platelet activation, or, in high shear settings, by enhancing
Table 5: Association between air pollution and blood parameters; 57 male patients with coronary heart disease
Erythrocytes [106/μl] Haemoglobin [g/dl]
%change mean 95% CI$ %change mean 95% CI
UFP§
lag0 -0.2 -0.7; 0.2 -0.4 -1.1; 0.2
lag1 -0.3 -0.8; 0.2 -0.4 -1.1; 0.3
lag2 0.0 -0.6; 0.5 0.0 -0.8; 0.7
lag3 -0.6* -1.3; 0.0 -0.3 -1.1; 0.5
5-day-average -0.5† -1.0; 0.1 -0.4 -1.1; 0.3
AP§
lag0 -0.1 -0.5; 0.3 -0.2 -0.7; 0.4
lag1 -0.4 -0.9; 0.2 -0.3 -1.0; 0.4
lag2 -0.4 -0.9; 0.2 -0.1 -0.9; 0.7
lag3 -0.4 -0.6; 0.3 -0.1 -0.8; 0.6
5-day-average -0.4 -1.0; 0.2 -0.2 -1.1; 0.6
PM2.5§
lag0 -0.1 -0.5; 0.3 0.0 -0.6; 0.5
lag1 -0.3 -0.7; 0.2 -0.2 -0.8; 0.3
lag2 -0.4* -0.8; 0.0 -0.5* -1.1; 0.0
lag3 -0.2 -0.5; 0.1 -0.2 -0.7; 0.2
5-day-average -0.4† -0.8; 0.0 -0.5† -1.0; 0.1
PM10§
lag0 0.0 -0.4; 0.5 -0.1 -0.7; 0.6
lag1 -0.4† -1.0; 0.1 -0.4 -1.2; 0.3
lag2 -0.7* -1.2; -0.2 -0.7† -1.3; 0.0
lag3 -0.4* -0.8; 0.0 -0.3 -0.9; 0.2
5-day-average -0.6* -1.2; -0.1 -0.7† -1.5; 0.1
*p < 0.05
† p < 0.10
§ UFP: ultrafine particles (number concentration of particles with a size range of 0.01 to 0.1 μm);
AP: accumulation mode particles (particles with a size range of 0.1 to 1.0 μm); PM2.5: mass concentration of particles less than 2.5 μm in diameter; 
PM10: mass concentration of particles less than 10 μm in diameter;
$CI: confidence intervalPage 9 of 14
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an increase in plasma levels of sCD40L at the same day,
and an equally large and significant reduction in sCD40L
72 hours later, while levels of platelets showed a consist-
ent decrease. This decrease in platelet count could be due
to changes in platelet activation, which allow them to
bind to other tissues such as lung, spleen and vascular
cells. Such an activation is expected to cause the platelets
to release some of their stores of sCD40L, which could
lead to the increased detection of plasma sCD40L. The
subsequent decrease in plasma sCD40L levels might be
caused by the activation of cells (caused in part by platelet
release of sCD40L and other proinflammatory mediators)
that now express heightened levels of CD40. Vascular
cells, B lymphocytes and fibroblasts can increase their sur-
face expression of CD40 after activation [43,44]. Increases
in the cellular expression of CD40 would be predicted to
cause a lowering of blood sCD40L.
It has also been shown that platelet CD40L can activate
vascular cells, resulting in a production of proinflamma-
tory cytokines and cell adhesion molecules [15,14]. vWF,
for example, an important player in the coagulation of
platelets, bridges the gap between platelets and collagen,
which is exposed if endothelial cells are damaged [45]. In
previous analyses of the same panel we found a significant
increase in vWf in association with AP, UFP and PM10
[12]. An increase in vWf might be another explanation for
the observed decrease in platelets.
Other mechanisms are also conceivable. For example, par-
ticles could lead to a damage of endothelial cells, with a
subsequent adhesion and aggregation of platelets to the
damaged part of the vessel wall. Seaton et al. [41] attrib-
uted the decrease in platelets to an early consumption
coagulopathy secondary to a change in the adhesive prop-
erties of erythrocytes.
Leukocytes
In addition to the decreased levels of platelets we
observed a decrease in leukocytes, following the same
time pattern. Studies have linked particulate exposure to
the level of leukocytes [41,36,39,11,46], however results
are contradictory and different hypotheses regarding the
underlying mechanisms have been proposed. An increase
in leukocytes in association with air pollution is usually
interpreted as an indication for an increased inflamma-
tory response. A decrease in leukocytes on the other hand
is more difficult to explain and the explanations suggested
here can only be hypotheses. Similar to platelets, the low
levels in leukocytes we found in peripheral blood in asso-
ciation with an increase in particles, might be a conse-
quence of the increased levels of adhesion molecules.
Adhesion molecules like E-selectin and ICAM-1 mediate
the contact between circulating leukocytes and endothe-
lial cells. This way, leukocytes can leave the blood stream
and enter the subendothelial space [47-49]. Increased lev-
els of adhesion molecules in association with higher levels
of air pollution have been shown previously [38,12] sup-
porting the hypotheses above. However, the immediate
decrease in blood cells is not in line with the more delayed
increase in adhesion molecules.
Ghio et al. [39] found that levels of blood leukocytes
decreased in association with CAPs, while levels in bron-
chial lavage increased in healthy volunteers after exposure
to CAPs [50]. They attributed the decrease in peripheral
blood to an influx of leukocytes into the lower respiratory
tract following exposure to ambient particles.
A third possibility is that the decrease in leukocytes in
peripheral blood is the result of a prolonged or delayed
transit of leukocytes through the lungs following particle
induced vasoconstriction. Pietropaoli et al. [51] showed
that inhalation of carbon UFP for two hours reduced the
pulmonary diffusing capacity for carbon monoxide in
healthy subjects. Frampton et al. [52] reported that similar
exposures to UFP reduced the percentage of eosinophils
and basophils in peripheral blood, and reduced expres-
sion of adhesion molecules on peripheral blood mono-
cytes and granulocytes. Similar results were found in a
study on rats, which showed vasoconstriction of small
pulmonary arteries after short term exposure to CAPs [53].
These findings support the hypothesis that UFP cause pul-
monary vasoconstriction.
Erythrocytes and Haemoglobin
Regarding erythrocytes and haemoglobin our results are
in accordance with those of Seaton et al. [41] who found
significant decreases in erythrocytes and haemoglobin in
association with personal exposure to PM10 as well as with
city centre measured PM10. They found this decrease after
a 3-day average exposure to PM10, which fits our data
showing significant effects mainly for lag 2 and 3 and the
5-day average exposure. Seaton et al. suggested that after
an alteration of adhesive properties of passing erythro-
cytes they might adhere to the systemic capillaries and
therefore not be measurable in peripheral blood anymore.
Strengths and limitations
As there is no standard way determining sCD40L, several
methods have been used in previous studies and it has
been shown that the type of anti-coagulant and whether
plasma or serum is used may influence the sCD40L levels
[27]. However, in our study all samples were analysed at
the same time and under the same conditions. The assay
used for this study has been validated and a comparison
to a kit by Bender Biomedical (Bender Biomedical Sys-
tems, San Bruno, CA, USA) showed very similar results
[17]. Moreover, the change of the sCD40L level withinPage 10 of 14
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Schematic representation of the hypothesised mechanisms involved in direct vascular effects of particles or their translocated componentsFigure 3
Schematic representation of the hypothesised mechanisms involved in direct vascular effects of particles or 
their translocated components. * see Reference [12]. sCD40L: soluble CD40Ligand. vWF: von Willebrand factor.
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level, and therefore the assay itself cannot have influenced
the results.
Some of the measured biomarkers, for example leuko-
cytes, are influenced easily by health-related events such
as acute infection or surgery [36]. We therefore carefully
excluded the blood samples where the level of sCD40L
and blood cells potentially could have been strongly
influenced by another source than air pollution, like
infection or surgery. However, no samples were excluded
that revealed especially high or low levels of the respective
biomarker, if no plausible reason was apparent. We
observed the associations for changes of the population
mean of the respective markers. In contrast to earlier anal-
yses, for example for CRP [54], we did not observe only a
shift in the upper tail of the distribution. This indicates
that the effects of ambient air pollution may occur within
the physiological range of the biomarkers.
We are aware of the fact that leukocyte blood count is not
as significant a measure of the changes in blood cells as a
differential blood cell analysis. As we do not have a differ-
entiation, we cannot identify which type of leukocyte was
responsible for the observed changes.
A variety of pollutants have been used for the analyses, as
different pollutants may point towards different proper-
ties of the aerosol, and also represent different sources of
air pollution. By testing several outcomes and a set of air
pollutants, the possibility that some associations might
have been observed by chance cannot be excluded. As the
air pollution parameters are correlated, we considered
especially consistent patterns in the data as actual effects.
Moreover, thorough confounder adjustment for meteoro-
logical variables was done to rule out the possibility that
the detected associations resulted from meteorological
influences or seasonal differences.
Only one central measurement site was used for the col-
lection of ambient air pollution. The spatial representa-
tiveness of this site has been analyzed in detail previously
by Cyrys et al [55] who measured sulphate and PM10 lev-
els simultaneously at three additional monitoring sites in
the Erfurt area. The relatively high inter-site correlation
between the monitoring stations (0.69 – 0.98) indicated
that regional episodes of sulphates and PM10 in Erfurt can
be identified using one fixed monitoring site and that our
site was generally representative for the urban background
level of air pollution within Erfurt. Erfurt is a small city
with one air mass confined by a mountain ridge on three
sides and high rises on the fourth side. As most of the par-
ticipants of our panel were already retired, we assumed
that they spent the greater part of their day within the
vicinity of their residence within the city of Erfurt.
Janssen et al [56] showed in two European cities that
ambient, indoor and personal concentrations of PM2.5
were highly correlated. Ebelt et al. [57] also demonstrated
that the component of personal exposure due to outdoor
particles and ambient concentrations were highly corre-
lated, with a Pearson correlation coefficient of 0.81 for
PM2.5, of 0.71 for PM10 and of 0.73 for the coarse fraction
(PM10 – PM2.5). They concluded that their results add sup-
port for the use of ambient monitoring data in time series
analyses. Cyrys et al [58], who compared the relationship
of indoor and outdoor levels of fine particulate mass, par-
ticle number concentrations and black smoke (BS) con-
cluded that ambient concentrations of PM2.5 and BS can
be used as good approximation of indoor concentrations.
Our panel of subjects consisted of male patients, with a
history of heart disease, who were all on cardiac medica-
tion. Therefore, they represent a highly selected group and
might have reacted differently compared to female
patients or healthy persons. The chosen design attempted
to balance the ability to study effects on the inflammatory
system and to be representative for men with cardiovascu-
lar disease. A strength of our study is the achievement of
99% of all scheduled visits.
Conclusion
The results for sCD40L add important new evidence to the
hypothesis that higher levels of ambient air pollution lead
to an inflammatory response in patients with CHD.
Increased inflammation would increase the likelihood of
serious arterial vascular thrombotic events in susceptible
individuals such as patients with CHD, possibly explain-
ing, in part, the observed association between air pollu-
tion and cardiovascular morbidity and mortality.
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